These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 21771759

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy.
    Tsuboi N, Kawamura T, Ishii T, Utsunomiya Y, Hosoya T.
    Nephrol Dial Transplant; 2009 Mar; 24(3):892-9. PubMed ID: 18922859
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis.
    Haruhara K, Tsuboi N, Kanzaki G, Koike K, Suyama M, Shimizu A, Miyazaki Y, Kawamura T, Ogura M, Yokoo T.
    Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380
    [Abstract] [Full Text] [Related]

  • 7. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 8. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate.
    Okonogi H, Utsunomiya Y, Miyazaki Y, Koike K, Hirano K, Tsuboi N, Suzuki T, Hara Y, Ogura M, Hosoya T, Kawamura T.
    Nephron Clin Pract; 2011 Aug; 118(3):c292-300. PubMed ID: 21212693
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy.
    Kataoka H, Ohara M, Honda K, Mochizuki T, Nitta K.
    Nephrol Dial Transplant; 2011 Dec; 26(12):3937-43. PubMed ID: 21427079
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Dec; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults.
    Koike K, Tsuboi N, Utsunomiya Y, Kawamura T, Hosoya T.
    Am J Nephrol; 2011 Dec; 34(6):542-8. PubMed ID: 22123493
    [Abstract] [Full Text] [Related]

  • 15. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Dec; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 16. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.